The German drugmaker acquired Monsanto, an agrochemical and agricultural biotechnology company, in 2018 for $63 billion. Along with it, Bayer acquired Roundup, an herbicide that thousands of plaintiffs have said caused their cancer.
Though the lawsuits are ongoing, about 93 percent of shareholders voted in favor of Mr. Baumann at the most recent shareholder meeting. He lost the vote last year, as shareholders were upset over the fallout of the Monsanto acquisition, according to Bloomberg.
The investors expressed some continued frustration that the lawsuits have yet to be resolved, but the confidence vote reflects their patience with Bayer’s efforts to resolve the litigation, Bloomberg reported.
Read the full article here.
More articles on pharmacy:
Top 15 specialty pharmacies by revenue
CVS to offer self-swab COVID-19 tests at 1,000 pharmacies
Walgreens to add COVID-19 testing sites in 49 states
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
